Infant lungs are preferentially infected by adenovirus and herpes simplex virus type 1 vectors: Role of the tissue mesenchymal cells

Journal of Gene Medicine

Volumn 13, Issue 2, 2011, Pages 101-113

  Massler, Anda ^a   Kolodkin Gal, Dror ^a   Meir, Karen ^b   Khalaileh, Abed ^b   Falk, Haya ^a   Izhar, Uzi ^b   Shufaro, Yoel ^b   Panet, Amos ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Adenovirus; Gene therapy; Herpes simplex virus type 1; Infant; Lung; Mesenchymal cells

Indexed keywords

ADENOVIRUS VECTOR; HERPES SIMPLEX VIRUS 1 VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FETUS; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INFANT; LUNG INFECTION; LUNG PARENCHYMA; MALE; MESENCHYME CELL; MOUSE; NEWBORN; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; TISSUE MESENCHYME CELL; VIRAL TROPISM; VIRUS INFECTION;

ADENOVIRIDAE; ADULT; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CERCOPITHECUS AETHIOPS; FETUS; GENES, REPORTER; GENETIC VECTORS; HEK293 CELLS; HERPESVIRUS 1, HUMAN; HUMANS; INFANT; LUNG; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; VERO CELLS; VIRUS INTERNALIZATION;

ADENOVIRIDAE; HUMAN HERPESVIRUS 1; MURINAE;

EID: 79952647322     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1544     Document Type: Article

References (48)

1. Lee TW, Matthews DA, Blair GE. Novel molecular approaches to cystic fibrosis gene therapy. Biochem J 2005; 387: 1-15.
2. Crystal RG, McElvaney NG, Rosenfeld MA, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8: 42-51.
3. Harvey BG, Maroni J, O'Donoghue KA, et al. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther 2002; 13: 15-63.
4. Flotte TR, Laube BL. Gene therapy in cystic fibrosis. Chest 2001; 120: 124S-131S.
5. Griesenbach U, Geddes DM, Alton EW. Gene therapy for cystic fibrosis: an example for lung gene therapy. Gene Ther 2004; 11(Suppl 1): S43-S50.
6. Kolodkin-Gal D, Zamir G, Pikarski E, et al. A novel system to study adenovirus tropism to normal and malignant colon tissues. Virology 2007; 357: 91-101.
7. Buckley SM, Howe SJ, Sheard V, et al. Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression. Gene Ther 2008; 15: 1167-1175.
8. Douar AM, Adebakin S, Themis M, et al. Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus. Gene Ther 1997; 4: 883-890.
9. Zepeda M, Wilson JM. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors. Gene Ther 1996; 3: 973-979.
10. Roberts DM, Nanda A, Havenga MJ, et al. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 2006; 441: 239-243.
11. Meier O, Greber UF. Adenovirus endocytosis. J Gene Med 2004; 6(Suppl 1): S152-S163.
12. Noutsias M, Fechner H, de Jonge H, et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 2001; 104: 275-280.
13. Greenberg SB. Respiratory herpesvirus infections. An overview. Chest 1994; 106: 1S-2S.
14. Knezevic A, Martic J, Stanojevic M, et al. Disseminated neonatal herpes caused by herpes simplex virus types 1 and 2. Emerg Infect Dis 2007; 13: 302-304.
15. Spear PG. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 2004; 6: 401-410.
16. Kolodkin-Gal D, Zamir G, Edden Y, et al. Herpes simplex virus type 1 preferentially targets human colon carcinoma: role of extracellular matrix. J Virol 2008; 82: 999-1010.
17. Pickles RJ, Fahrner JA, Petrella JM, et al. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J Virol 2000; 74: 6050-6057.
18. Nociari M, Ocheretina O, Schoggins JW, et al. Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J Virol 2007; 81: 4145-4157.
19. Brill-Almon E, Stern B, Afik D, et al. Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. Mol Ther 2005; 12: 274-282.
20. Hasson E, Slovatizky Y, Shimoni Y, et al. Solid tissues can be manipulated ex vivo and used as vehicles for gene therapy. J Gene Med 2005; 7: 926-935.
21. Kunicher N, Falk H, Yaacov B, et al. Tropism of lentiviral vectors in skin tissue. Hum Gene Ther 2008; 19: 255-266.
22. Prevec L, Christie BS, Laurie KE, et al. Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys. J Acquir Immune Defic Syndr 1991; 4: 568-576.
23. Wu H, Seki T, Dmitriev I, et al. Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency. Hum Gene Ther 2002; 13: 1647-1653.
24. Alian A, Sela-Donenfeld D, Panet A, et al. Avian hemangioma retrovirus induces cell proliferation via the envelope (env) gene. Virology 2000; 276: 161-168.
25. Thomas SK, Gough G, Latchman DS, et al. Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency. J Virol 1999; 73: 6618-6625.
26. Zhang JG, Ghosh S, Ockleford CD, et al. Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischaemia and reperfusion in man. Clin Sci (Lond) 2000; 99: 443-453.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
28. Braun E, Zimmerman T, Hur TB, et al. Neurotropism of herpes simplex virus type 1 in brain organ cultures. J Gen Virol 2006; 87: 2827-2837.
29. Cao B, Pruchnic R, Ikezawa M, et al. The role of receptors in the maturation-dependent adenoviral transduction of myofibers. Gene Ther 2001; 8: 627-637.
30. Blair GE, Dixon SC, Griffiths SA, et al. Restricted replication of human adenovirus type 5 in mouse cell lines. Virus Res 1989; 14: 339-346.
31. Arcasoy SM, Latoche J, Gondor M, et al. MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells. Am J Respir Cell Mol Biol 1997; 17: 422-435.
32. Harrod KS, Trapnell BC, Otake K, et al. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am J Physiol 1999; 277: L580-588.
33. Ramanathan R. Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS. J Perinatol 2006; 26(Suppl 1): S51-S56.
34. Blau S, Levin N, Schwartz B, et al. Adsorption of cationized bovine serum albumin onto epithelial crypt fractions of the rat colon. J Pharm Sci 2001; 90: 1516-1522.
35. Chu Q, St George JA, Lukason M, et al. EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo. Hum Gene Ther 2001; 12: 455-467.
36. Marozin S, Prank U, Sodeik B. Herpes simplex virus type 1 infection of polarized epithelial cells requires microtubules and access to receptors present at cell-cell contact sites. J Gen Virol 2004; 85: 775-786.
37. Kreda SM, Gynn MC, Fenstermacher DA, et al. Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol 2001; 24: 224-234.
38. Brasch F, Birzele J, Ochs M, et al. Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J 2004; 24: 426-435.
39. Khalil N, Xu YD, O'Connor R, et al. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J Biol Chem 2005; 280: 43000-43009.
40. Griesenbach U, Alton EW. Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy. Adv Drug Deliv Rev 2009; 61: 128-139.
41. Chuang YY, Chiu CH, Wong KS, et al. Severe adenovirus infection in children. J Microbiol Immunol Infect 2003; 36: 37-40.
42. Tsai HP, Kuo PH, Liu CC, et al. Respiratory viral infections among pediatric inpatients and outpatients in Taiwan from 1997 to 1999. J Clin Microbiol 2001; 39: 111-118.
43. Kotecha S. Lung growth: implications for the newborn infant. Arch Dis Child Fetal Neonatal Ed 2000; 82: F69-F74.
44. Thurlbeck WM. Postnatal human lung growth. Thorax 1982; 37: 564-571.
45. Burri PH. Fetal and postnatal development of the lung. Annu Rev Physiol 1984; 46: 617-628.
46. Sabatini F, Petecchia L, Tavian M, et al. Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest 2005; 85: 962-971.
47. Nakagome K, Dohi M, Okunishi K, et al. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung. Thorax 2006; 61: 886-894.
48. Knipe DM, Cliffe A. Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 2008; 6: 211-221.